Powered by

Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference

Aug 06, 2019 - GlobeNewswire
Event Announcements

EVANSTON, Ill., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that Norbert Riedel, Ph.D., president and chief executive officer, will present at the 2019 Wedbush PacGrow Healthcare Conference. The presentation will take place at 4:15 p.m. ET on August 13, 2019 at the Parker New York in New York, NY.  

A live audio webca...